Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oberic, L."'
Autor:
Lapierre L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Pericart S; Department of Pathology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Protin C; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Borel C; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Ysebaert L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Laurent C; Department of Pathology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France., Oberic L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 3063-3065. Date of Electronic Publication: 2021 Jul 13.
Autor:
Compaci G; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopôle, Toulouse, France., Conte C; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France.; Laboratory of Medical and Clinical Pharmacology Faculty of Medicine, University III Paul Sabatier, Toulouse, France.; INSERM Unit 1027, Faculty of Medicine, The French National Institute of Health and Medical Research, Toulouse, France., Oberic L; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopôle, Toulouse, France., Ysebaert L; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopôle, Toulouse, France.; INSERM Unit 1037, Center of Cancer Research, The French National Institute of Health and Medical Research, Toulouse, France., Laurent G; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopôle, Toulouse, France.; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France., Despas F; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France. fabien.despas@univ-tlse3.fr.; Laboratory of Medical and Clinical Pharmacology Faculty of Medicine, University III Paul Sabatier, Toulouse, France. fabien.despas@univ-tlse3.fr.; INSERM Unit 1027, Faculty of Medicine, The French National Institute of Health and Medical Research, Toulouse, France. fabien.despas@univ-tlse3.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Dec 03; Vol. 19 (1), pp. 1178. Date of Electronic Publication: 2019 Dec 03.
Autor:
Deau B; Hopital Cochin, Paris, France., Amorim S; Hopital Saint Louis, Paris, France., Perrot A; CHU Nancy, Vandroeuvre, France., Quittet P; CHU Montpellier, Montpellier, France., Cornillon J; Institut Cancerologique de la Loire, St-Priest en Jarez, France., Chaoui D; CH Argenteuil, Argenteuil, France., Marolleau JP; CH Amiens, Amiens, France., Oberic L; CHU Toulouse, Toulouse, France., Le Du K; Clinique Victor Hugo Le Mans, Le Mans, France., Fornecker LM; CHU Strasbourg, Strasbourg, France., Tournilhac O; CHU Clermont Ferrand, Clermont-Ferrand, France., Veillard AS; Lymphoma Academic Research Organisation (LYSARC), Lyon, France., Chaillol I; Lymphoma Academic Research Organisation (LYSARC), Lyon, France., Robin M; Hopital Saint Louis, Paris, France., Tamburini J; Hopital Cochin, Paris, France., Brice P; Hopital Saint Louis, Paris, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2018 May; Vol. 181 (3), pp. 341-349. Date of Electronic Publication: 2018 Apr 02.
Autor:
Compaci G; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopole, Toulouse, France. compaci.gisele@iuct-oncopole.fr., Rueter M; INSERM Unit 1027 (The French National Institute of Health and Medical Research), Faculty of Medicine, Toulouse, France. rueter.m@chu-toulouse.fr.; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France. rueter.m@chu-toulouse.fr., Lamy S; INSERM Unit 1027 (The French National Institute of Health and Medical Research), Faculty of Medicine, Toulouse, France. sebastien.lamy@univ-tlse3.fr.; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France. sebastien.lamy@univ-tlse3.fr.; Department of Epidemiology, Health Economics and Public Health, Faculty of Medicine, University of Toulouse III Paul Sabatier, Toulouse, France. sebastien.lamy@univ-tlse3.fr., Oberic L; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopole, Toulouse, France. oberic.lucie@iuct-oncopole.fr., Recher C; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopole, Toulouse, France. recher.christian@iuct-oncopole.fr.; INSERM Unit 1037 (The French National Institute of Health and Medical Research), Center of Cancer Research, Toulouse, France. recher.christian@iuct-oncopole.fr., Lapeyre-Mestre M; INSERM Unit 1027 (The French National Institute of Health and Medical Research), Faculty of Medicine, Toulouse, France. maryse.lapeyre-mestre@univ-tlse3.fr.; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France. maryse.lapeyre-mestre@univ-tlse3.fr.; Laboratory of Medical and Clinical Pharmacology Faculty of Medicine, University III Paul Sabatier, Toulouse, France. maryse.lapeyre-mestre@univ-tlse3.fr., Laurent G; Department of Hematology - Internal Medicine, Toulouse University Hospital, Cancer University Institute of Toulouse Oncopole, Toulouse, France. laurent.guy@iuct-oncopole.fr.; INSERM Unit 1027 (The French National Institute of Health and Medical Research), Faculty of Medicine, Toulouse, France. laurent.guy@iuct-oncopole.fr., Despas F; INSERM Unit 1027 (The French National Institute of Health and Medical Research), Faculty of Medicine, Toulouse, France. fabien.despas@univ-tlse3.fr.; Service of Medical and Clinical Pharmacology, Center of Pharmacovigilance, Pharmaco-epidemiology and Information on Drugs, Toulouse University Hospital, 37 Allées Jules Guesde, 31000, Toulouse, France. fabien.despas@univ-tlse3.fr.; Laboratory of Medical and Clinical Pharmacology Faculty of Medicine, University III Paul Sabatier, Toulouse, France. fabien.despas@univ-tlse3.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Oct 24; Vol. 15, pp. 781. Date of Electronic Publication: 2015 Oct 24.